Price T Rowe Associates Inc Tandem Diabetes Care Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 45,200 shares of TNDM stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,200
Previous 44,791 0.91%
Holding current value
$1.36 Million
Previous $1.81 Million 6.2%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$35.21 - $47.3 $14,400 - $19,345
409 Added 0.91%
45,200 $1.92 Million
Q2 2024

Aug 14, 2024
BUY
$30.43 - $53.43 $184,375 - $323,732
6,059 Added 15.64%
44,791 $1.81 Million
Q1 2024

May 15, 2024
BUY
$22.09 - $35.41 $43,848 - $70,288
1,985 Added 5.4%
38,732 $1.37 Million
Q4 2023

Feb 14, 2024
BUY
$14.28 - $31.03 $27,574 - $59,918
1,931 Added 5.55%
36,747 $1.09 Million
Q3 2023

Nov 14, 2023
BUY
$19.33 - $36.22 $53,872 - $100,945
2,787 Added 8.7%
34,816 $724,000
Q2 2023

Aug 14, 2023
SELL
$24.18 - $42.46 $6.27 Million - $11 Million
-259,162 Reduced 89.0%
32,029 $786,000
Q1 2023

May 15, 2023
BUY
$35.86 - $46.5 $33,170 - $43,012
925 Added 0.32%
291,191 $11.8 Million
Q4 2022

Feb 14, 2023
SELL
$35.49 - $56.15 $4.03 Million - $6.38 Million
-113,679 Reduced 28.14%
290,266 $13 Million
Q3 2022

Nov 14, 2022
SELL
$43.76 - $68.97 $10.1 Million - $16 Million
-231,499 Reduced 36.43%
403,945 $19.3 Million
Q2 2022

Aug 15, 2022
BUY
$53.22 - $123.09 $412,295 - $953,578
7,747 Added 1.23%
635,444 $37.6 Million
Q1 2022

May 16, 2022
BUY
$101.89 - $150.09 $395,944 - $583,249
3,886 Added 0.62%
627,697 $73 Million
Q4 2021

Feb 14, 2022
SELL
$118.18 - $153.21 $3.13 Million - $4.06 Million
-26,494 Reduced 4.07%
623,811 $93.9 Million
Q3 2021

Nov 15, 2021
SELL
$93.51 - $129.4 $12.3 Million - $17 Million
-131,038 Reduced 16.77%
650,305 $77.6 Million
Q2 2021

Aug 16, 2021
SELL
$77.0 - $100.19 $24.1 Million - $31.4 Million
-312,972 Reduced 28.6%
781,343 $76.1 Million
Q1 2021

May 17, 2021
SELL
$81.28 - $104.34 $22.5 Million - $28.9 Million
-277,065 Reduced 20.2%
1,094,315 $96.6 Million
Q4 2020

Feb 16, 2021
BUY
$86.4 - $121.75 $118 Million - $167 Million
1,371,380 New
1,371,380 $131 Million

Others Institutions Holding TNDM

# of Institutions
360
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.94B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email